SEC 13F Intelligence

VTGNUSDVISTAGEN THERAPEUTICS INC

CUSIP 92840H202 · Yahoo Finance ↗ · Google Finance ↗

Vistagen Therapeutics Inc (VTGNUSD) has 76 institutional holders in Filings Flow’s 13F database, together reporting 16.91M shares worth $718,784 as of Q4 2022.

Institutional Holders
76
Q4 2022
Reported Value
$718,784
Ticker
VTGNUSD
Quarters Tracked
7

Ownership Trend

Institutional holders
Q4 ’18: 18Q4 ’18Q1 ’19: 21Q1 ’19Q2 ’19: 16Q2 ’19Q3 ’19: 17Q3 ’19Q2 ’21: 90Q2 ’21Q4 ’21: 91Q4 ’21Q4 ’22: 76Q4 ’22filingsflow.com
Total reported value
Q4 ’18: $4MQ4 ’18Q1 ’19: $6MQ1 ’19Q2 ’19: $1MQ2 ’19Q3 ’19: $2MQ3 ’19Q2 ’21: $339MQ2 ’21Q4 ’21: $285MQ4 ’21Q4 ’22: $718,784Q4 ’22filingsflow.com

Holders

Export to Excel
Manager% of PortfolioValueSharesQuarter
TCG Crossover Management, LLC$3.5B AUM0.97%$9M2.68MQ2 2024

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.